Lypo Gold
On sale on the US market (according to the DSLD)
Enzymedica, food supplement from the US market
Lypo Gold (Enzymedica), a food supplement au code-barres 670480981306, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Lypo Gold
Entered into DSLD on 18 July 2023. Withdrawn from the US market on 21 August 2023 (according to the DSLD).- Active ingredient added : Carbohydrate Digestion (quantity not stated)
- Active ingredient added : Fat Digestion (quantity not stated)
- Active ingredient added : Protein Digestion (quantity not stated)
Official label: Lypo Gold
Entered into DSLD on 22 January 2022. On sale on the US market (according to the DSLD).- Active ingredient added : Amylase Thera-blend (quantity not stated)
- Active ingredient added : Carbohydrate Digestion (quantity not stated)
- Active ingredient added : Fat Digestion (quantity not stated)
- Active ingredient added : Lipase Thera-blend (quantity not stated)
- Active ingredient added : Protease Thera-blend (quantity not stated)
- Active ingredient added : Protein Digestion (quantity not stated)
- Active ingredient removed : Amylase (quantity not stated)
- Active ingredient removed : Lipase (quantity not stated)
- Active ingredient removed : Protease (quantity not stated)
Official label: Lypo Gold
Entered into DSLD on 25 April 2014. Withdrawn from the US market on 31 August 2022 (according to the DSLD).- Active ingredient added : Amylase Thera-blend (11,000 DU)
- Active ingredient added : Lactase (600 ALU)
- Active ingredient removed : Amylase (quantity not stated)
- Different unit, without conversion : Lipase: 6,000 FCCFIP in this version; quantity not stated on the displayed label
- Different unit, without conversion : Protease: 30,000 HUT in this version; quantity not stated on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : Enzymedica
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.